Transmembrane Prolyl 4 Hydroxylase Market

Global Transmembrane Prolyl 4 Hydroxylase Market Size, Share and Trends Analysis Report, By Type (Daprodustat, Dimethyloxalylglycine, FG-2216, FG-4497, and Others), By Application (Anemia, Inflammatory Bowel Disease, Brain Edema, Colitis and Others), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2026060 | Category : Healthcare Information Technology | Delivery Format: /

The global transmembrane prolyl 4 hydroxylase market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Transmembrane prolyl 4-hydroxylase (P4H-TM) is a member of the P4H family. Additionally, biallelic loss of function P4H-TM mutations causes a syndromic form of severe cognitive impairment in humans. The major factor driving the demand for transmembrane prolyl 4 hydroxylase market is the increasing prevalence of colitis across the globe. 

According to the National Center for Biotechnology Information (NCBI), ulcerative colitis has an incidence rate of 9 to 20 cases per 100,000 persons per year globally. Additionally, its prevalence is 156 to 291 cases per 100,000 persons per year across the globe. Furthermore, it has a greater prevalence in adults compared to Crohn's disease. Hence, the increasing prevalence of colitis is driving the demand for transmembrane prolyl 4 hydroxylase. 

Moreover, North America hold a prominent share in the market owing to the presence of an advanced healthcare infrastructure as well as the presence of key players in the region. Additionally, the market is also growing due to the increasing application of transmembrane prolyl 4 hydroxylase in several diseases such as inflammatory bowel disease, among others. Some major players in the market include Astellas Pharma Inc., and GlaxoSmithKline Plc, among others.  

Market Coverage

The market number available for – 2020-2027

Base year- 2020

Forecast period- 2021-2027

Segment Covered- 

o By Type

o By Application

Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape- Astellas Pharma Inc., and GlaxoSmithKline Plc, among others. 

Key questions addressed by the report

What is the market growth rate?

Which segment and region dominate the market in the base year?

Which segment and region will project the fastest growth in the market?

How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?

How players are addressing challenges to sustain growth?

Where is the investment opportunity?

Global Transmembrane Prolyl 4 Hydroxylase Market Report by Segment

By Type

Daprodustat

Dimethyloxalylglycine

FG-22216

FG-4497

Others

By Application

Anemia

Inflammatory Bowel Dosease

Brain

Edema

Colitis

Others

Global Transmembrane Prolyl 4 Hydroxylase Market Report by Region

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe 

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific 

Rest of the World

Latin America 

Middle East & Africa